Both Cyclophilin Inhibitors and Direct-Acting Antivirals Prevent PKR Activation in HCV-Infected CellsMichael Bobardt(Scripps Research Institute), Philippe Gallay(Scripps Research Institute)The Open Virology JournalMarch 7, 201410.2174/1874357901408010001Cited by 9SaveCiteExport RISWatch citationsRelated PapersThe cyclophilin inhibitor CRV431 inhibits liver HBV DNA and HBsAg in transgenic mice|PLoS ONE|2019|41